GATE (Graduate Aptitude Test in Engineering) Pharmaceutical Engineering: Questions 56 - 61 of 120

Access detailed explanations (illustrated with images and videos) to 120 questions. Access all new questions- tracking exam pattern and syllabus. View the complete topic-wise distribution of questions. Unlimited Access, Unlimited Time, on Unlimited Devices!

View Sample Explanation or View Features.

Rs. 150.00 -OR-

How to register? Already Subscribed?

Question 56

Appeared in Year: 1990

Question

MCQ▾

The mechanism of action of rifampicin involve

Choices

Choice (4)Response

a.

Inhibition of bacterial DNA directed RNA polymerase

b.

Inhibition of transpeptidase

c.

Inhibition of mycolic acid synthesis

d.

Inhibition of protein synthesis

Question 57

Appeared in Year: 2002

Question

MCQ▾

The instrument used to measure particle volume is:

Choices

Choice (4)Response

a.

Microscope

b.

Helium Densitometer

c.

Hempel Burette

d.

Coulter counter

Question 58

Appeared in Year: 1990

Question

MCQ▾

The colligative property are related to the

Choices

Choice (4)Response

a.

Number of ingredients

b.

pH

c.

Total number of solute particles

d.

Number of ions

Question 59

Appeared in Year: 2002

Question

MCQ▾

Ion exchange capacity of a resin is dependent upon:

Choices

Choice (4)Response

a.

The total number of ion active groups

b.

Length of the ion exchange resin

c.

The total molecular weight of the resin

d.

Solubility of ion exchange resin

Question 60

Appeared in Year: 1998

Question

MCQ▾

The dip tube of aerosol container is made from one of the following. Choose the correct one

Choices

Choice (4)Response

a.

Polypropylene

b.

Stainless steel

c.

Glass

d.

Aluminium

Question 61

Appeared in Year: 2001

Question

MCQ▾

The loading dose of a drug is usually based on:

Choices

Choice (4)Response

a.

Total body clearance of the drug

b.

Fraction of drug bound to plasma proteins

c.

Apparent volume of distribuion and desired plasma drug concentration

d.

Percentage of drug bound to plasma protein

Developed by: